ヘパリンの世界市場2022-2028:ヘパリンナトリウム、ヘパリンカルシウム

■ 英語タイトル:Global Heparin Market Growth 2022-2028

調査会社LP Information社が発行したリサーチレポート(データ管理コード:LP22DC4996)■ 発行会社/調査会社:LP Information
■ 商品コード:LP22DC4996
■ 発行日:2022年12月
■ 調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
■ 産業分野:医薬品
■ ページ数:112
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール(受注後2-3営業日)
■ 販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥556,320見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥834,480見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥1,112,640見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能)
LP Information社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[ヘパリンの世界市場2022-2028:ヘパリンナトリウム、ヘパリンカルシウム]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

ヘパリンのグローバル市場規模は、2021年のxxx百万ドルから2028年までにxxx百万ドルに増加すると推定されており、2022年~2028年の年平均成長率(CAGR)はxx%を示しています。COVID-19とロシア・ウクライナ戦争の不確実性を念頭に置いて、さまざまな最終用途部門に対するパンデミックの直接的および間接的な影響を継続的に追跡・分析しています。これらのインサイトは、主要な市場要因としてレポートに含まれています。
ヘパリンのアジア太平洋市場は、2022年にxxx百万ドルの市場規模が見込まれ、2022年~2028年にかけて約xx%のCAGRで成長すると予想されています。ヘパリンの米国市場は、2022年にxxx百万ドルの規模があり、2022年~2028年にかけて約xx%のCAGRで成長すると予想されています。ヘパリンのヨーロッパ市場は、2022年にxxx百万ドルの規模が見込まれ、2022年~2028年にかけて約xx%のCAGRで成長すると予想されています。ヘパリンの中国市場は、2022年にxxx百万ドルの規模があり、2022年~2028年にかけて約xx%のCAGRで成長すると予想されています。

世界の主要なヘパリン関連企業としては、Shenzhen Hepalink Pharmaceutical、 Yantai Dongcheng Pharmaceutical、 Nanjing King-friend Biochemical Pharmaceutical、 Pfizer、 Hebei Changshan Biochemical Pharmaceutical、 Bioibérica、 Qingdao Jiulong Biopharmaceutical、 Changzhou Qianhong Biopharma、 Dongying Tiandong Pharmaceutical、 Opocrin、 Hubei Enoray Biopharmaceutical、 Yino Pharma、 Cisen Pharmaceutical、 Nanjing Xinbai Pharmaceutical、 Sichuan Deebio Pharmaceuticalなどをカバーしています。売上の面では世界最大の2社が2021年にほぼxx%の市場シェアを占めています。

*** レポート範囲 ***

この最新のレポートはすべての重要な側面をカバーしながらヘパリンのグローバル市場に関する深いインサイトを提供します。これは、市場のマクロな概要から、市場規模、競争環境、開発動向、ニッチ市場、主要な市場ドライバーと課題、バリュー チェーン分析などのミクロの詳細にまで及びます。当レポートは読者がパンデミックおよびロシア・ウクライナ戦争中に世界中でヘパリン市場シナリオがどのように変化したかを理解できるように定量的データと定性的データの両方を使用して、ヘパリンのグローバル市場の全体像を提供することを目的としています。

分析の対象となる基準年は2021年で、市場の予測は2022年~2028年までのものです。

*** 市場セグメンテーション ***

この調査ではヘパリン市場を細分化し、種類別 (ヘパリンナトリウム、ヘパリンカルシウム)、用途別 (UFH、LMWH)、および地域別 (アジア太平洋、アメリカ州、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分:ヘパリンナトリウム、ヘパリンカルシウム

・用途別区分:UFH、LMWH

・地域別区分
アメリカ州(アメリカ、カナダ、メキシコ、ブラジル)
APAC/アジア太平洋(中国、日本、韓国、東南アジア、インド、オーストラリア)
ヨーロッパ(ドイツ、フランス、イギリス、イタリア、ロシア)
中東・アフリカ(エジプト、南アフリカ、イスラエル、トルコ、GCC諸国)

*** 各章の紹介 ***
第1章:ヘパリンの範囲、調査方法など
第2章:エグゼクティブサマリー、世界のヘパリン市場規模 (販売量、売上) およびCAGR、地域別・種類別・用途別、2017年~2022年までの推移データ、および2028年までの市場予測
第3章:企業別ヘパリンの販売量、売上、平均価格、グローバル市場シェア、および業界ランキング
第4章:地域別および国別のヘパリンの販売量と売上(米国、カナダ、ヨーロッパ、中国、日本、韓国、東南アジア、インド、ラテンアメリカ、中東・アフリカなど)
第5/6/7/8章:アメリカ州、アジア太平洋、ヨーロッパ、中東・アフリカの国別、種類別の販売セグメント
第9章:市場動向、市場予測、機会、将来の市場に影響を与える経済動向の分析
第10章:製造コスト構造分析
第11章:販売チャンネル、販売業者および顧客
第12章:地域別、国別、種類別、用途別の世界のヘパリン市場規模予測
第13章:主要企業の包括的な企業プロファイル
第14章:調査の結果

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要:ヘパリンの年間販売量2017-2028、地域別現状・将来分析
・ヘパリンの種類別セグメント:ヘパリンナトリウム、ヘパリンカルシウム
・ヘパリンの種類別販売量:2017-2022年の販売量、売上、市場シェア、販売価格
・ヘパリンの用途別セグメント:UFH、LMWH
・ヘパリンの用途別販売量:2017-2022年の販売量、売上、市場シェア、販売価格

企業別世界のヘパリン市場
・企業別のグローバルヘパリン市場データ:2020-2022年の年間販売量、市場シェア
・企業別のヘパリンの年間売上:2020-2022年の売上、市場シェア
・企業別のヘパリン販売価格
・主要企業のヘパリン生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

ヘパリンの地域別レビュー
・地域別のヘパリン市場規模2017-2022:年間販売量、売上
・主要国別のヘパリン市場規模2017-2022:年間販売量、売上
・アメリカ州のヘパリン販売の成長
・アジア太平洋のヘパリン販売の成長
・ヨーロッパのヘパリン販売の成長
・中東・アフリカのヘパリン販売の成長

アメリカ州市場
・アメリカ州の国別のヘパリン販売量、売上(2017-2022)
・アメリカ州のヘパリンの種類別販売量
・アメリカ州のヘパリンの用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋(APAC)市場
・アジア太平洋の国別のヘパリン販売量、売上(2017-2022)
・アジア太平洋のヘパリンの種類別販売量
・アジア太平洋のヘパリンの用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のヘパリン販売量、売上(2017-2022)
・ヨーロッパのヘパリンの種類別販売量
・ヨーロッパのヘパリンの用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のヘパリン販売量、売上(2017-2022)
・中東・アフリカのヘパリンの種類別販売量
・中東・アフリカのヘパリンの用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・ヘパリンの製造コスト構造分析
・ヘパリンの製造プロセス分析
・ヘパリンの産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル:直接販売チャンネル、間接販売チャンネル
・ヘパリンの主要なグローバル販売業者
・ヘパリンの主要なグローバル顧客

地域別のヘパリン市場予測レビュー
・地域別のヘパリン市場規模予測(2023-2028)
・アメリカ州の国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・ヘパリンの種類別市場規模予測
・ヘパリンの用途別市場規模予測

主要企業分析
Shenzhen Hepalink Pharmaceutical、 Yantai Dongcheng Pharmaceutical、 Nanjing King-friend Biochemical Pharmaceutical、 Pfizer、 Hebei Changshan Biochemical Pharmaceutical、 Bioibérica、 Qingdao Jiulong Biopharmaceutical、 Changzhou Qianhong Biopharma、 Dongying Tiandong Pharmaceutical、 Opocrin、 Hubei Enoray Biopharmaceutical、 Yino Pharma、 Cisen Pharmaceutical、 Nanjing Xinbai Pharmaceutical、 Sichuan Deebio Pharmaceutical
・企業情報
・ヘパリン製品
・ヘパリン販売量、売上、価格、粗利益(2020-2022)
・主要ビジネス概要
・最新動向

調査の結果

Heparin is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium.
The global market for Heparin is estimated to increase from US$ 2213.7 million in 2021 to reach US$ 5244.3 million by 2028, exhibiting a CAGR of 13.1% during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Global key players of Heparin include Shenzhen Hepalink Pharmaceutical, Yantai Dongcheng Pharmaceutical, Nanjing King-friend Biochemical Pharmaceutical, Pfizer, Hebei Changshan Biochemical Pharmaceutical, etc. The top five manufacturers hold a share about 54%. China is dominating the global Heparin market, has a share over 65% in terms of production. Europe and Asia-Pacific are the two largest market, both having a share about 34%, followed by North America, with a share about 30 percent.

[Report Coverage]
This latest report provides a deep insight into the global Heparin market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Heparin market, with both quantitative and qualitative data, to help readers understand how the Heparin market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in B Units.

[Market Segmentation]
The study segments the Heparin market and forecasts the market size by Type (Heparin Sodium and Heparin Calcium,), by Application (UFH and LMWH.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Heparin Sodium
Heparin Calcium
Segmentation by application
UFH
LMWH
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Shenzhen Hepalink Pharmaceutical
Yantai Dongcheng Pharmaceutical
Nanjing King-friend Biochemical Pharmaceutical
Pfizer
Hebei Changshan Biochemical Pharmaceutical
Bioibérica
Qingdao Jiulong Biopharmaceutical
Changzhou Qianhong Biopharma
Dongying Tiandong Pharmaceutical
Opocrin
Hubei Enoray Biopharmaceutical
Yino Pharma
Cisen Pharmaceutical
Nanjing Xinbai Pharmaceutical
Sichuan Deebio Pharmaceutical

[Chapter Introduction]
Chapter 1: Scope of Heparin, Research Methodology, etc.
Chapter 2: Executive Summary, global Heparin market size (sales and revenue) and CAGR, Heparin market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Heparin sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Heparin sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Heparin market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Shenzhen Hepalink Pharmaceutical, Yantai Dongcheng Pharmaceutical, Nanjing King-friend Biochemical Pharmaceutical, Pfizer, Hebei Changshan Biochemical Pharmaceutical, Bioibérica, Qingdao Jiulong Biopharmaceutical, Changzhou Qianhong Biopharma and Dongying Tiandong Pharmaceutical, etc.
Chapter 14: Research Findings and Conclusion

世界の市場調査レポート販売サイト(H&Iグローバルリサーチ株式会社運営)
*** レポート目次(コンテンツ)***

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Heparin Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Heparin by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Heparin by Country/Region, 2017, 2022 & 2028
2.2 Heparin Segment by Type
2.2.1 Heparin Sodium
2.2.2 Heparin Calcium
2.3 Heparin Sales by Type
2.3.1 Global Heparin Sales Market Share by Type (2017-2022)
2.3.2 Global Heparin Revenue and Market Share by Type (2017-2022)
2.3.3 Global Heparin Sale Price by Type (2017-2022)
2.4 Heparin Segment by Application
2.4.1 UFH
2.4.2 LMWH
2.5 Heparin Sales by Application
2.5.1 Global Heparin Sale Market Share by Application (2017-2022)
2.5.2 Global Heparin Revenue and Market Share by Application (2017-2022)
2.5.3 Global Heparin Sale Price by Application (2017-2022)
3 Global Heparin by Company
3.1 Global Heparin Breakdown Data by Company
3.1.1 Global Heparin Annual Sales by Company (2020-2022)
3.1.2 Global Heparin Sales Market Share by Company (2020-2022)
3.2 Global Heparin Annual Revenue by Company (2020-2022)
3.2.1 Global Heparin Revenue by Company (2020-2022)
3.2.2 Global Heparin Revenue Market Share by Company (2020-2022)
3.3 Global Heparin Sale Price by Company
3.4 Key Manufacturers Heparin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Heparin Product Location Distribution
3.4.2 Players Heparin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Heparin by Geographic Region
4.1 World Historic Heparin Market Size by Geographic Region (2017-2022)
4.1.1 Global Heparin Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Heparin Annual Revenue by Geographic Region
4.2 World Historic Heparin Market Size by Country/Region (2017-2022)
4.2.1 Global Heparin Annual Sales by Country/Region (2017-2022)
4.2.2 Global Heparin Annual Revenue by Country/Region
4.3 Americas Heparin Sales Growth
4.4 APAC Heparin Sales Growth
4.5 Europe Heparin Sales Growth
4.6 Middle East & Africa Heparin Sales Growth
5 Americas
5.1 Americas Heparin Sales by Country
5.1.1 Americas Heparin Sales by Country (2017-2022)
5.1.2 Americas Heparin Revenue by Country (2017-2022)
5.2 Americas Heparin Sales by Type
5.3 Americas Heparin Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Heparin Sales by Region
6.1.1 APAC Heparin Sales by Region (2017-2022)
6.1.2 APAC Heparin Revenue by Region (2017-2022)
6.2 APAC Heparin Sales by Type
6.3 APAC Heparin Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Heparin by Country
7.1.1 Europe Heparin Sales by Country (2017-2022)
7.1.2 Europe Heparin Revenue by Country (2017-2022)
7.2 Europe Heparin Sales by Type
7.3 Europe Heparin Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Heparin by Country
8.1.1 Middle East & Africa Heparin Sales by Country (2017-2022)
8.1.2 Middle East & Africa Heparin Revenue by Country (2017-2022)
8.2 Middle East & Africa Heparin Sales by Type
8.3 Middle East & Africa Heparin Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Heparin
10.3 Manufacturing Process Analysis of Heparin
10.4 Industry Chain Structure of Heparin
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Heparin Distributors
11.3 Heparin Customer
12 World Forecast Review for Heparin by Geographic Region
12.1 Global Heparin Market Size Forecast by Region
12.1.1 Global Heparin Forecast by Region (2023-2028)
12.1.2 Global Heparin Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Heparin Forecast by Type
12.7 Global Heparin Forecast by Application
13 Key Players Analysis
13.1 Shenzhen Hepalink Pharmaceutical
13.1.1 Shenzhen Hepalink Pharmaceutical Company Information
13.1.2 Shenzhen Hepalink Pharmaceutical Heparin Product Offered
13.1.3 Shenzhen Hepalink Pharmaceutical Heparin Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Shenzhen Hepalink Pharmaceutical Main Business Overview
13.1.5 Shenzhen Hepalink Pharmaceutical Latest Developments
13.2 Yantai Dongcheng Pharmaceutical
13.2.1 Yantai Dongcheng Pharmaceutical Company Information
13.2.2 Yantai Dongcheng Pharmaceutical Heparin Product Offered
13.2.3 Yantai Dongcheng Pharmaceutical Heparin Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Yantai Dongcheng Pharmaceutical Main Business Overview
13.2.5 Yantai Dongcheng Pharmaceutical Latest Developments
13.3 Nanjing King-friend Biochemical Pharmaceutical
13.3.1 Nanjing King-friend Biochemical Pharmaceutical Company Information
13.3.2 Nanjing King-friend Biochemical Pharmaceutical Heparin Product Offered
13.3.3 Nanjing King-friend Biochemical Pharmaceutical Heparin Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Nanjing King-friend Biochemical Pharmaceutical Main Business Overview
13.3.5 Nanjing King-friend Biochemical Pharmaceutical Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Heparin Product Offered
13.4.3 Pfizer Heparin Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 Hebei Changshan Biochemical Pharmaceutical
13.5.1 Hebei Changshan Biochemical Pharmaceutical Company Information
13.5.2 Hebei Changshan Biochemical Pharmaceutical Heparin Product Offered
13.5.3 Hebei Changshan Biochemical Pharmaceutical Heparin Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Hebei Changshan Biochemical Pharmaceutical Main Business Overview
13.5.5 Hebei Changshan Biochemical Pharmaceutical Latest Developments
13.6 Bioibérica
13.6.1 Bioibérica Company Information
13.6.2 Bioibérica Heparin Product Offered
13.6.3 Bioibérica Heparin Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Bioibérica Main Business Overview
13.6.5 Bioibérica Latest Developments
13.7 Qingdao Jiulong Biopharmaceutical
13.7.1 Qingdao Jiulong Biopharmaceutical Company Information
13.7.2 Qingdao Jiulong Biopharmaceutical Heparin Product Offered
13.7.3 Qingdao Jiulong Biopharmaceutical Heparin Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Qingdao Jiulong Biopharmaceutical Main Business Overview
13.7.5 Qingdao Jiulong Biopharmaceutical Latest Developments
13.8 Changzhou Qianhong Biopharma
13.8.1 Changzhou Qianhong Biopharma Company Information
13.8.2 Changzhou Qianhong Biopharma Heparin Product Offered
13.8.3 Changzhou Qianhong Biopharma Heparin Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Changzhou Qianhong Biopharma Main Business Overview
13.8.5 Changzhou Qianhong Biopharma Latest Developments
13.9 Dongying Tiandong Pharmaceutical
13.9.1 Dongying Tiandong Pharmaceutical Company Information
13.9.2 Dongying Tiandong Pharmaceutical Heparin Product Offered
13.9.3 Dongying Tiandong Pharmaceutical Heparin Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Dongying Tiandong Pharmaceutical Main Business Overview
13.9.5 Dongying Tiandong Pharmaceutical Latest Developments
13.10 Opocrin
13.10.1 Opocrin Company Information
13.10.2 Opocrin Heparin Product Offered
13.10.3 Opocrin Heparin Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Opocrin Main Business Overview
13.10.5 Opocrin Latest Developments
13.11 Hubei Enoray Biopharmaceutical
13.11.1 Hubei Enoray Biopharmaceutical Company Information
13.11.2 Hubei Enoray Biopharmaceutical Heparin Product Offered
13.11.3 Hubei Enoray Biopharmaceutical Heparin Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Hubei Enoray Biopharmaceutical Main Business Overview
13.11.5 Hubei Enoray Biopharmaceutical Latest Developments
13.12 Yino Pharma
13.12.1 Yino Pharma Company Information
13.12.2 Yino Pharma Heparin Product Offered
13.12.3 Yino Pharma Heparin Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Yino Pharma Main Business Overview
13.12.5 Yino Pharma Latest Developments
13.13 Cisen Pharmaceutical
13.13.1 Cisen Pharmaceutical Company Information
13.13.2 Cisen Pharmaceutical Heparin Product Offered
13.13.3 Cisen Pharmaceutical Heparin Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Cisen Pharmaceutical Main Business Overview
13.13.5 Cisen Pharmaceutical Latest Developments
13.14 Nanjing Xinbai Pharmaceutical
13.14.1 Nanjing Xinbai Pharmaceutical Company Information
13.14.2 Nanjing Xinbai Pharmaceutical Heparin Product Offered
13.14.3 Nanjing Xinbai Pharmaceutical Heparin Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Nanjing Xinbai Pharmaceutical Main Business Overview
13.14.5 Nanjing Xinbai Pharmaceutical Latest Developments
13.15 Sichuan Deebio Pharmaceutical
13.15.1 Sichuan Deebio Pharmaceutical Company Information
13.15.2 Sichuan Deebio Pharmaceutical Heparin Product Offered
13.15.3 Sichuan Deebio Pharmaceutical Heparin Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Sichuan Deebio Pharmaceutical Main Business Overview
13.15.5 Sichuan Deebio Pharmaceutical Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Heparin Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Heparin Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Heparin Sodium
Table 4. Major Players of Heparin Calcium
Table 5. Global Heparin Sales by Type (2017-2022) & (B Units)
Table 6. Global Heparin Sales Market Share by Type (2017-2022)
Table 7. Global Heparin Revenue by Type (2017-2022) & ($ million)
Table 8. Global Heparin Revenue Market Share by Type (2017-2022)
Table 9. Global Heparin Sale Price by Type (2017-2022) & (US$/B Units)
Table 10. Global Heparin Sales by Application (2017-2022) & (B Units)
Table 11. Global Heparin Sales Market Share by Application (2017-2022)
Table 12. Global Heparin Revenue by Application (2017-2022)
Table 13. Global Heparin Revenue Market Share by Application (2017-2022)
Table 14. Global Heparin Sale Price by Application (2017-2022) & (US$/B Units)
Table 15. Global Heparin Sales by Company (2020-2022) & (B Units)
Table 16. Global Heparin Sales Market Share by Company (2020-2022)
Table 17. Global Heparin Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Heparin Revenue Market Share by Company (2020-2022)
Table 19. Global Heparin Sale Price by Company (2020-2022) & (US$/B Units)
Table 20. Key Manufacturers Heparin Producing Area Distribution and Sales Area
Table 21. Players Heparin Products Offered
Table 22. Heparin Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Heparin Sales by Geographic Region (2017-2022) & (B Units)
Table 26. Global Heparin Sales Market Share Geographic Region (2017-2022)
Table 27. Global Heparin Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Heparin Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Heparin Sales by Country/Region (2017-2022) & (B Units)
Table 30. Global Heparin Sales Market Share by Country/Region (2017-2022)
Table 31. Global Heparin Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Heparin Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Heparin Sales by Country (2017-2022) & (B Units)
Table 34. Americas Heparin Sales Market Share by Country (2017-2022)
Table 35. Americas Heparin Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Heparin Revenue Market Share by Country (2017-2022)
Table 37. Americas Heparin Sales by Type (2017-2022) & (B Units)
Table 38. Americas Heparin Sales Market Share by Type (2017-2022)
Table 39. Americas Heparin Sales by Application (2017-2022) & (B Units)
Table 40. Americas Heparin Sales Market Share by Application (2017-2022)
Table 41. APAC Heparin Sales by Region (2017-2022) & (B Units)
Table 42. APAC Heparin Sales Market Share by Region (2017-2022)
Table 43. APAC Heparin Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Heparin Revenue Market Share by Region (2017-2022)
Table 45. APAC Heparin Sales by Type (2017-2022) & (B Units)
Table 46. APAC Heparin Sales Market Share by Type (2017-2022)
Table 47. APAC Heparin Sales by Application (2017-2022) & (B Units)
Table 48. APAC Heparin Sales Market Share by Application (2017-2022)
Table 49. Europe Heparin Sales by Country (2017-2022) & (B Units)
Table 50. Europe Heparin Sales Market Share by Country (2017-2022)
Table 51. Europe Heparin Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Heparin Revenue Market Share by Country (2017-2022)
Table 53. Europe Heparin Sales by Type (2017-2022) & (B Units)
Table 54. Europe Heparin Sales Market Share by Type (2017-2022)
Table 55. Europe Heparin Sales by Application (2017-2022) & (B Units)
Table 56. Europe Heparin Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Heparin Sales by Country (2017-2022) & (B Units)
Table 58. Middle East & Africa Heparin Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Heparin Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Heparin Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Heparin Sales by Type (2017-2022) & (B Units)
Table 62. Middle East & Africa Heparin Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Heparin Sales by Application (2017-2022) & (B Units)
Table 64. Middle East & Africa Heparin Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Heparin
Table 66. Key Market Challenges & Risks of Heparin
Table 67. Key Industry Trends of Heparin
Table 68. Heparin Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Heparin Distributors List
Table 71. Heparin Customer List
Table 72. Global Heparin Sales Forecast by Region (2023-2028) & (B Units)
Table 73. Global Heparin Sales Market Forecast by Region
Table 74. Global Heparin Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Heparin Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Heparin Sales Forecast by Country (2023-2028) & (B Units)
Table 77. Americas Heparin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Heparin Sales Forecast by Region (2023-2028) & (B Units)
Table 79. APAC Heparin Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Heparin Sales Forecast by Country (2023-2028) & (B Units)
Table 81. Europe Heparin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Heparin Sales Forecast by Country (2023-2028) & (B Units)
Table 83. Middle East & Africa Heparin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Heparin Sales Forecast by Type (2023-2028) & (B Units)
Table 85. Global Heparin Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Heparin Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Heparin Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Heparin Sales Forecast by Application (2023-2028) & (B Units)
Table 89. Global Heparin Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Heparin Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Heparin Revenue Market Share Forecast by Application (2023-2028)
Table 92. Shenzhen Hepalink Pharmaceutical Basic Information, Heparin Manufacturing Base, Sales Area and Its Competitors
Table 93. Shenzhen Hepalink Pharmaceutical Heparin Product Offered
Table 94. Shenzhen Hepalink Pharmaceutical Heparin Sales (B Units), Revenue ($ Million), Price (US$/B Units) and Gross Margin (2020-2022)
Table 95. Shenzhen Hepalink Pharmaceutical Main Business
Table 96. Shenzhen Hepalink Pharmaceutical Latest Developments
Table 97. Yantai Dongcheng Pharmaceutical Basic Information, Heparin Manufacturing Base, Sales Area and Its Competitors
Table 98. Yantai Dongcheng Pharmaceutical Heparin Product Offered
Table 99. Yantai Dongcheng Pharmaceutical Heparin Sales (B Units), Revenue ($ Million), Price (US$/B Units) and Gross Margin (2020-2022)
Table 100. Yantai Dongcheng Pharmaceutical Main Business
Table 101. Yantai Dongcheng Pharmaceutical Latest Developments
Table 102. Nanjing King-friend Biochemical Pharmaceutical Basic Information, Heparin Manufacturing Base, Sales Area and Its Competitors
Table 103. Nanjing King-friend Biochemical Pharmaceutical Heparin Product Offered
Table 104. Nanjing King-friend Biochemical Pharmaceutical Heparin Sales (B Units), Revenue ($ Million), Price (US$/B Units) and Gross Margin (2020-2022)
Table 105. Nanjing King-friend Biochemical Pharmaceutical Main Business
Table 106. Nanjing King-friend Biochemical Pharmaceutical Latest Developments
Table 107. Pfizer Basic Information, Heparin Manufacturing Base, Sales Area and Its Competitors
Table 108. Pfizer Heparin Product Offered
Table 109. Pfizer Heparin Sales (B Units), Revenue ($ Million), Price (US$/B Units) and Gross Margin (2020-2022)
Table 110. Pfizer Main Business
Table 111. Pfizer Latest Developments
Table 112. Hebei Changshan Biochemical Pharmaceutical Basic Information, Heparin Manufacturing Base, Sales Area and Its Competitors
Table 113. Hebei Changshan Biochemical Pharmaceutical Heparin Product Offered
Table 114. Hebei Changshan Biochemical Pharmaceutical Heparin Sales (B Units), Revenue ($ Million), Price (US$/B Units) and Gross Margin (2020-2022)
Table 115. Hebei Changshan Biochemical Pharmaceutical Main Business
Table 116. Hebei Changshan Biochemical Pharmaceutical Latest Developments
Table 117. Bioibérica Basic Information, Heparin Manufacturing Base, Sales Area and Its Competitors
Table 118. Bioibérica Heparin Product Offered
Table 119. Bioibérica Heparin Sales (B Units), Revenue ($ Million), Price (US$/B Units) and Gross Margin (2020-2022)
Table 120. Bioibérica Main Business
Table 121. Bioibérica Latest Developments
Table 122. Qingdao Jiulong Biopharmaceutical Basic Information, Heparin Manufacturing Base, Sales Area and Its Competitors
Table 123. Qingdao Jiulong Biopharmaceutical Heparin Product Offered
Table 124. Qingdao Jiulong Biopharmaceutical Heparin Sales (B Units), Revenue ($ Million), Price (US$/B Units) and Gross Margin (2020-2022)
Table 125. Qingdao Jiulong Biopharmaceutical Main Business
Table 126. Qingdao Jiulong Biopharmaceutical Latest Developments
Table 127. Changzhou Qianhong Biopharma Basic Information, Heparin Manufacturing Base, Sales Area and Its Competitors
Table 128. Changzhou Qianhong Biopharma Heparin Product Offered
Table 129. Changzhou Qianhong Biopharma Heparin Sales (B Units), Revenue ($ Million), Price (US$/B Units) and Gross Margin (2020-2022)
Table 130. Changzhou Qianhong Biopharma Main Business
Table 131. Changzhou Qianhong Biopharma Latest Developments
Table 132. Dongying Tiandong Pharmaceutical Basic Information, Heparin Manufacturing Base, Sales Area and Its Competitors
Table 133. Dongying Tiandong Pharmaceutical Heparin Product Offered
Table 134. Dongying Tiandong Pharmaceutical Heparin Sales (B Units), Revenue ($ Million), Price (US$/B Units) and Gross Margin (2020-2022)
Table 135. Dongying Tiandong Pharmaceutical Main Business
Table 136. Dongying Tiandong Pharmaceutical Latest Developments
Table 137. Opocrin Basic Information, Heparin Manufacturing Base, Sales Area and Its Competitors
Table 138. Opocrin Heparin Product Offered
Table 139. Opocrin Heparin Sales (B Units), Revenue ($ Million), Price (US$/B Units) and Gross Margin (2020-2022)
Table 140. Opocrin Main Business
Table 141. Opocrin Latest Developments
Table 142. Hubei Enoray Biopharmaceutical Basic Information, Heparin Manufacturing Base, Sales Area and Its Competitors
Table 143. Hubei Enoray Biopharmaceutical Heparin Product Offered
Table 144. Hubei Enoray Biopharmaceutical Heparin Sales (B Units), Revenue ($ Million), Price (US$/B Units) and Gross Margin (2020-2022)
Table 145. Hubei Enoray Biopharmaceutical Main Business
Table 146. Hubei Enoray Biopharmaceutical Latest Developments
Table 147. Yino Pharma Basic Information, Heparin Manufacturing Base, Sales Area and Its Competitors
Table 148. Yino Pharma Heparin Product Offered
Table 149. Yino Pharma Heparin Sales (B Units), Revenue ($ Million), Price (US$/B Units) and Gross Margin (2020-2022)
Table 150. Yino Pharma Main Business
Table 151. Yino Pharma Latest Developments
Table 152. Cisen Pharmaceutical Basic Information, Heparin Manufacturing Base, Sales Area and Its Competitors
Table 153. Cisen Pharmaceutical Heparin Product Offered
Table 154. Cisen Pharmaceutical Heparin Sales (B Units), Revenue ($ Million), Price (US$/B Units) and Gross Margin (2020-2022)
Table 155. Cisen Pharmaceutical Main Business
Table 156. Cisen Pharmaceutical Latest Developments
Table 157. Nanjing Xinbai Pharmaceutical Basic Information, Heparin Manufacturing Base, Sales Area and Its Competitors
Table 158. Nanjing Xinbai Pharmaceutical Heparin Product Offered
Table 159. Nanjing Xinbai Pharmaceutical Heparin Sales (B Units), Revenue ($ Million), Price (US$/B Units) and Gross Margin (2020-2022)
Table 160. Nanjing Xinbai Pharmaceutical Main Business
Table 161. Nanjing Xinbai Pharmaceutical Latest Developments
Table 162. Sichuan Deebio Pharmaceutical Basic Information, Heparin Manufacturing Base, Sales Area and Its Competitors
Table 163. Sichuan Deebio Pharmaceutical Heparin Product Offered
Table 164. Sichuan Deebio Pharmaceutical Heparin Sales (B Units), Revenue ($ Million), Price (US$/B Units) and Gross Margin (2020-2022)
Table 165. Sichuan Deebio Pharmaceutical Main Business
Table 166. Sichuan Deebio Pharmaceutical Latest Developments
List of Figures
Figure 1. Picture of Heparin
Figure 2. Heparin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Heparin Sales Growth Rate 2017-2028 (B Units)
Figure 7. Global Heparin Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Heparin Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Heparin Sodium
Figure 10. Product Picture of Heparin Calcium
Figure 11. Global Heparin Sales Market Share by Type in 2021
Figure 12. Global Heparin Revenue Market Share by Type (2017-2022)
Figure 13. Heparin Consumed in UFH
Figure 14. Global Heparin Market: UFH (2017-2022) & (B Units)
Figure 15. Heparin Consumed in LMWH
Figure 16. Global Heparin Market: LMWH (2017-2022) & (B Units)
Figure 17. Global Heparin Sales Market Share by Application (2017-2022)
Figure 18. Global Heparin Revenue Market Share by Application in 2021
Figure 19. Heparin Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Heparin Revenue Market Share by Company in 2021
Figure 21. Global Heparin Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Heparin Revenue Market Share by Geographic Region in 2021
Figure 23. Global Heparin Sales Market Share by Region (2017-2022)
Figure 24. Global Heparin Revenue Market Share by Country/Region in 2021
Figure 25. Americas Heparin Sales 2017-2022 (B Units)
Figure 26. Americas Heparin Revenue 2017-2022 ($ Millions)
Figure 27. APAC Heparin Sales 2017-2022 (B Units)
Figure 28. APAC Heparin Revenue 2017-2022 ($ Millions)
Figure 29. Europe Heparin Sales 2017-2022 (B Units)
Figure 30. Europe Heparin Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Heparin Sales 2017-2022 (B Units)
Figure 32. Middle East & Africa Heparin Revenue 2017-2022 ($ Millions)
Figure 33. Americas Heparin Sales Market Share by Country in 2021
Figure 34. Americas Heparin Revenue Market Share by Country in 2021
Figure 35. United States Heparin Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Heparin Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Heparin Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Heparin Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Heparin Sales Market Share by Region in 2021
Figure 40. APAC Heparin Revenue Market Share by Regions in 2021
Figure 41. China Heparin Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Heparin Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Heparin Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Heparin Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Heparin Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Heparin Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Heparin Sales Market Share by Country in 2021
Figure 48. Europe Heparin Revenue Market Share by Country in 2021
Figure 49. Germany Heparin Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Heparin Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Heparin Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Heparin Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Heparin Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Heparin Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Heparin Revenue Market Share by Country in 2021
Figure 56. Egypt Heparin Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Heparin Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Heparin Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Heparin Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Heparin Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Heparin in 2021
Figure 62. Manufacturing Process Analysis of Heparin
Figure 63. Industry Chain Structure of Heparin
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/



※注目の調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(LP22DC4996 )"ヘパリンの世界市場2022-2028:ヘパリンナトリウム、ヘパリンカルシウム" (英文:Global Heparin Market Growth 2022-2028)はLP Information社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。